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Ceramide as central second messenger of the apoptosis-related sphingomyelin signaling pathway is a potential
target for the control of cancer. A complex metabolizing network deﬁnes cell type and stage-speciﬁc ﬁnal ceramide
concentrations. Successful therapeutic control of ceramide levels requires a knowledge of multiple related
turnover rates. The metabolism of ceramide and sphingomyelin was studied in keratinocytes under the condition of
an unstimulated sphingomyelin signaling pathway. Preparations enriched in plasma membranes contain a neutral
Mg2þ -dependent sphingomyelinase and a Mg2þ -independent sphingomyelin synthase that vigorously preserve
balanced ceramide and sphingomyelin levels. Ceramide regulates neutral sphingomyelinase. Inhibition of
sphingomyelin synthase by D609 treatment results in temporary loss of intercelluar contacts and in cellular
shrinking. It is ineffective for sustained elevation of ceramide levels. Ceramide phosphorylating and deacylating
activities are insigniﬁcant. Recently, fatty-acid remodeling in sphingomyelin was reported as likely to counteract
the membrane-rigidifying effects of cholesterol. Keratinocytes transfer ﬂuorescence labeled acyl-chains between
phosphatidylcholine and sphingomyelin. A transferase of that kind would allow rapid adjustment of local lipid
composition in response to acutely changed conditions. In addition, this transferase might have a function in the
formation of the epidermal permeability barrier.
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The major polar lipid constituents of membranes are the
glycerophospholipid phosphatidylcholine (PC) and the phos-
phosphingolipid sphingomyelin (SM). PC and SM share phos-
phocholine as their polar head group. PC further consists of
glycerol and of two esterified acyl-chains, while SM cont-
ains the sphingoid base sphingosine and an amide-linked
acyl-chain. In difference to most biological phospholipids,
the acyl-chains of SM are mostly long and largely saturated.
This acyl-chain structure allows a more dense and ordered
packing of molecules likely to result in the formation of
specialized functional microdomains like the SM- and
cholesterol-rich structures called rafts (Brown and London,
2000; Holthuis et al, 2001; Sprong et al, 2001). In addition to
serving as structural components, the membrane lipids are
sources of bioactive derivatives. An SM-based signaling
pathway was proposed in 1988 (Kloesnick and Clegg, 1988)
with the hydrolyzed SM metabolite ceramide (Cer) as
central second messenger (Okazaki et al, 1990). Cer may
be degraded to the effector sphingosine. Cer may be
phosphorylated either directly to the bioactive lipid cer-
amide 1-phosphate or to sphingosine 1-phosphate, after
deacylation respectively. Alternatively, Cer may either be
glycosylated to generate glycosphingolipids or be con-
verted back to SM by transfer of a phosphocholine moiety.
If derived from PC, bioactive diacylglycerol arises at the
expense of Cer (Hannun et al, 2001). Deacylation of SM
generates another second messenger, sphingosylpho-
sphorylcholine (Meyer zu Heringdorf et al, 2002) (Scheme
1). SM pathway-related lipids show individual signaling
functions and may generate even contrasting outcomes. In
most cell types, Cer signaling for instance is connected
with cell cycle arrest, differentiation, or apoptosis, whereas
sphingosine 1-phosphate is more related to proliferation or
inhibition of apoptosis (Cuvillier et al, 1996). The bioactive
Scheme 1
A part of the ceramide network.
Abbreviations: Cer, ceramide; C2-Cer, N-acetyl-sphingosine; D609,
tricyclodecan-9-yl-xanthate; DG, diacylglycerol; fl, fluorescent;
HPTLC, high-performance thin-layer chromatography; LCAT,
lecithin–cholesterol acyltransferase; PBS, phosphate-buffered
saline; PC, phosphatidylcholine; PC-PLC, phosphatidylcholine-
specific phospholipase C; SM, sphingomyelin; SMase, sphingo-
myelinase; SMS, sphingomyelin synthase
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SM derivatives also differ in their physical properties.
Individual concentration changes may affect membrane
characteristics such as local fluidity. SM and its derivatives
are substrates and products of interconnected metabolic
pathways. Changing the concentration of any sphingolipid
will result in changes in concentrations of other metabolites,
depending on the activities of the enzymes involved.
Apoptosis-related signaling pathways have emerged as
key targets for the control of cancer. Of the multitude of SM
metabolites, Cer in particular has been shown to stimulate
cell death (Kolesnick, 2002). The biological effects of
potential therapeutic Cer analogs as well as of compounds
modulating metabolic activities surrounding Cer depend,
however, on cell type or phase-specific adjustments of the
turnover rates of multiple molecules related to the SM
network (Hannun et al, 2001). This study focuses on the
turnover of SM and Cer applied to keratinocytes under the
condition of an unstimulated SM signaling pathway.
Fluorophore-labeled lipid analogs are reasonable substi-
tutes for membrane lipids in terms of packing similarity
(Dahim et al, 2002) and, regarding metabolizing enzymes,
they proved to be substrates comparable to radioactive
probes (He et al, 1999; Loidl et al, 2002). SM- and Cer-
analogs labeled with the fluorophore BODIPY FL were used
to disturb the SM–Cer homeostasis. Provoked SM–Cer
imbalances were found to be rapidly levelled off at the
plasma membrane already. Further SM- or Cer-derived
bioactive lipids were not substantially generated from the
fluorescent analogs applied; however, an activity remodel-
ing the acyl-chain composition of SM via transfer from
fluorescent PC was detected.
Results
Rapid readjustment of disturbed ceramide and sphin-
gomyelin homeostasis Confluent HaCaT keratinocyte
cultures were labeled at 41C with fluorescent BODIPY FL
C5-ceramide (fl-Cer) or BODIPY FL C5-sphingomyelin (fl-
SM). In the cold, the fluorescent lipids were incorporated
into the plasma membranes (Fig 1a). A shift to 371C caused
the fluorescent molecules to move to intracellular compart-
ments. Regarding labeling with fl-Cer, the initial diffuse
cytoplasmic staining visibly concentrated in the Golgi
stacks after 15 min, already (Fig 1b). Labeling with fl-SM
also stained the Golgi stacks, which was visible after 30 min
at 371C. After 90 min, staining was also detectable inside
the nuclei (not shown). The incorporated lipids were quickly
and quantitatively metabolized. HPTLC analysis showed,
120 min after temperature shift, a nearly 70% conversion of
fl-Cer to fl-SM and a 25% hydrolysis of fl-SM to fl-Cer (Fig
1c). Half-maximal turnover rates were achieved at time
points below 5 min (Fig 1c). At 3 h after the addition of fl-Cer
and fl-SM, the disturbed ceramide and sphingomyelin
homeostasis was readjusted (Fig 1d ). Other products of
added fl-Cer and fl-SM were limited amounts of glycolipids,
which were detectable not until reactions had proceeded for
at least 2 h (Fig 1d ).
HaCaT keratinocyte cultures that were treated on
alternate days with either 5 mM fl-Cer, 10 mM C2-Cer, or
vehicle control 0.1% DMSO grew up to comparable cell
numbers (not shown). After application of 10 mM C2-Cer,
FACS analysis revealed no increased annexin V staining (not
shown).
BODIPY C5-phosphatidylcholine (fl-PC) was incorpo-
rated into plasma membranes in the cold and was partly
taken up intracellularly at 371C. Staining, however, did not
concentrate in specific organelles (not shown). Fl-PC was
not found to be metabolized (Fig 1d ). The BODIPY-labeled
PC proved, however, to be a good substrate for phospho-
lipase C type IV from B. cereus and for phospholipase A2
from bee venom (not shown).
Cer and SM metabolism in membrane preparations A
considerable fraction of added lipids was metabolized
before being transported to intracellular compartments.
This pointed to a localization of rapid metabolic activities
at the plasma membranes. As a proof, HaCaT keratinocyte
membranes were isolated by nitrogen cavitation and
differential centrifugation (Watarai et al, 2000). These
membrane preparations were negative for the golgi-marker
58k-protein (Fig 2). Alkaline phosphatase activity was 4-fold
enriched as compared with whole-cell homogenates (Fig 2).
The membrane preparations contained a strong initial fl-SM
hydrolyzing (SMase) activity, which quickly slowed down
(Fig 3a). SMase activity was Mg2þ -dependent (Fig 3b) and
reached a maximum at neutral pH (Fig 3c). Neutral SMase
activities, in isolated membranes prepared from normal
Figure1
HaCaT keratinocytes incorporate and quickly metabolize fluores-
cent sphingolipid analogs. BODIPY FL C5-ceramide (fl-Cer) added to
the cell culture medium at a concentration of 5 mM was incorporated
into plasma membranes at 41C (a), and 15 min after transfer to 371C at
the earliest, staining was visibly concentrated in the Golgi stacks as
determined by fluorescence microscopy (b). Lipid extraction at time
points after transfer to 371C as indicated and HPTLC revealed a rapid
conversion of fl-Cer to fluorescent sphingomyelin (SM) (  ). BODIPY FL
C5-SM (fl-SM) added at a concentration of 5 mM was rapidly hydrolyzed
to fl-Cer (’). The results of a typical experiment are shown (c). Cer and
SM homeostasis was readjusted at 3 h after the addition of fl-Cer or fl-
SM as indicated at the bottom. A fluorescent phosphatidylcholine
analog (PC) was not metabolized. A typical HPTLC plate is shown (d ).
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human keratinocytes were comparable to those in HaCaT
membrane preparations (not shown).
No SMase activity was found in membranes at pH 5.0. In
whole-cell homogenates of HaCaT keratinocytes, SMase
activity was at least 50 times stronger at neutral pH as
compared with pH 5.0 when measured after a 5 min
reaction time (Fig 3c). In homogenates of normal human
epidermis, SMase activities at pH 5.0 needed reaction times
of 3 h to become detectable, whereas at neutral pH, SMase
activities were comparable to HaCaT homogenates (not
shown). Epidermal acid SMase activity was abolished by
the presence of 1% Triton-X-100 (not shown). BODIPY-
labeled SM proved to be a good substrate for neutral
SMases from B. cereus and S. aureus as well as for acid
SMase prepared from human placenta (not shown).
The membrane preparations from HaCaT keratinocytes
generated fl-SM from added fl-Cer at metabolic rates in
the range of fl-SM hydrolysis (Fig 4). SM synthesis was
independent of both Mg2þ (Fig 4) and Ca2þ (not shown).
To confirm the reliability of the SMase and SMS assays
used, we determined the turnover rates of the fluorescent
lipid analogs at various ratios of fluorescent to natural lipids.
For both SM hydrolysis and SM synthesis, the turnover
rates of fluorescent lipids decreased linearly according to
replacement with their natural counterparts (Fig 5).
D609 inhibits both SM synthesis and SM hydrolysis SM
synthesis is not a monomolecular reaction like SM hydro-
lysis. To generate SM from Cer, a phosphocholine moiety is
needed. This moiety mainly originates from PC hydrolyzed
by a PC-specific phospholipase C (PC-PLC) (Spence,
1989). The xanthogenate compound D609 is both a
Figure 2
Keratinocyte membrane preparation is enriched in plasma mem-
branes. HaCaT keratinocyte membranes prepared by nitrogen cavita-
tion and differential centrifugation were enriched in activity of the
plasma membrane marker alkaline phosphatase (SD of three experi-
ments) and diminished in the Golgi-marker 58k-protein as shown by
immunoblotting (typical experiment) (M, membrane preparation; H,
whole-cell homogenate).
Figure 3
Keratinocyte membranes contain a neutral Mg2þ -dependent
SMase. Membranes of HaCaT keratinocytes isolated by nitrogen
cavitation and differential centrifugation hydrolyze fl-SM to fl-Cer. A
typical HPTLC plate and, below, the results of densitometrical
evaluations of five independent experiments (mean  SD) are shown
(a). SMase activity strongly depended on the presence of Mg2þ (,
without; þ , 5 mM Mg2þ ) (b). SMase activities in isolated membranes
(empty columns) and in whole-cell homogenates (filled columns) of
HaCaT keratinocytes in dependence of pH. Reactions were performed
in solutions containing 5 mM fl-SM, 5 mM Mg2þ , and 50 mM MOPS or
100 mM Na-phosphate with a pH as indicated, and proceeded for
5 min at 371C. Results represent % of activity relative to the condition
that yielded maximal activity in membranes or in homogenates,
respectively (mean  SD of three independent experiments) (c).
Figure4
Keratinocyte membranes contain a Mg2þ -independent SM
synthase. Membranes of HaCaT keratinocytes isolated by nitrogen
cavitation and differential centrifugation convert fl-Cer to fl-SM.
Reactions were performed at 371C in a solution containing 5 mM fl-
Cer, 5 mM Mg2þ (’), or 20 mM EDTA (  ) at pH 7.4 and proceeded for
times as indicated. Intensities of fl-SM on HPTLC plates were
densitometrically evaluated and compared with intensities of fl-SM
standards. A typical experiment is shown.
Figure5
SMase and SMS do not discriminate against fluorescent lipid
analogs. Initial SMase (  ) and SMS turnover rates (’) were
determined in dependence of replacement of fl-SM with natural SM
from bovine brain and of fl-Cer with C18-Cer at ratios as indicated. Total
saturating substrate concentrations were 5 mM, and HaCaT keratino-
cyte membranes were added at a protein concentration of 0.2 mg per
mL. (SD of three independent experiments).
PHOSPHOLIPID HOMEOSTASIS AND REMODELING 775122 : 3 MARCH 2004
supposed potent and specific inhibitor of PC-PLC (Wieg-
mann et al, 1994; Luberto et al, 2000) (Scheme 1).
Confluent HaCaT keratinocyte cultures labeled with fl-
Cer were treated either with D609 at a final concentration of
0.1 mM or with vehicle control DMSO at 0.1%. D609
decreased the part of Cer converted to SM from 20% to
10% after a reaction time of 5 min (Fig 6a). After 30 min, no
difference was detectable between D609 and vehicle con-
trol treatment (Fig 6a). The influence of D609 on sphingolipid
metabolism was investigated in isolated HaCaT keratino-
cyte membranes also. Either D609 at 0.1 mM or DMSO at
0.1% final concentration was added to the membranes, and
reactions were allowed to proceed for 5 min at 371C. Both
the synthesis of SM and its hydrolysis were inhibited by
D609 as compared with vehicle control (Fig 6b). In
additional experiments, HaCaT keratinocyte cultures were
treated with D609 as described above, but no fl-Cer was
added, and the dishes were incubated at 371C for up to 5 h.
The main lipid classes of the intact whole cells were
detected in comparable amounts, regardless of whether
they were treated with D609 or with vehicle control (Fig 6c).
On microscopical examination, corresponding D609-trea-
ted cell cultures revealed striking morphological changes.
Treated cells shrank and lost their contacts to neighboring
cells (Fig 6da,b). The enlargement of the intercellular spaces
was not due to removal of non-adhering cells as nuclear
staining revealed the same numbers of nuclei in equal areas
of D609- and DMSO-treated keratinocyte cultures (Fig
6dc,d). In contrast to vehicle controls, no mitotically active
cells were found in D609-treated cell cultures (Fig 6dc,d).
The shrunk cells were viable as observed by fluorescence
microscopy. 7-Amino-actinomycin D and annexin V-PE
hardly ever stained cells or plasma membranes, respec-
tively (not shown). The morphological changes had a
maximum at 5 h after D609 application. Thereafter, the
keratinocyte cultures recovered to normal appearances. At
18 h after application, D609-treated cell cultures were
microscopically indistinguishable from controls (not shown).
BODIPY-labeled phosphatidylcholine apparently in-
creases sphingomyelin synthesis To study the influence
of PC on the homeostasis of Cer and SM more directly, PC
in combination with 5 mM fl-Cer was added to HaCaT
membranes. The addition of 200 mM unlabeled PC revealed
Figure 6
The PC-PLC inhibitor D609 inhibits
activities of both SMase and SMS in
keratinocyte membranes. HaCaT kerati-
nocyte cultures were treated 5 mM fl-Cer
and with D609 at a final concentration of
0.1 mM (’) or with DMSO at 0.1% (  ),
and conversion of fl-Cer to fl-SM was
determined after reaction times as indi-
cated. A typical HPTLC plate and its
densitometrical evaluation are shown;
mean  SD of two independent experi-
ments (a). D609 at a final concentration of
0.1 mM or DMSO at 0.1% were added to
dispersions containing HaCaT keratino-
cyte membranes, 5 mM Mg2þ , and 5 mM
fl-Cer or 5 mM fl-SM, respectively. Con-
versions to fl-SM and fl-Cer were deter-
mined after reaction times of 5 min at
371C. Results of three independent ex-
periments are shown; mean  SD (b).
HaCaT keratinocyte cultures were treated
with D609 at a final concentration of 0.1
mM or with DMSO at 0.1%, and after
cultivation times, as indicated, endogen-
ous lipids were extracted and separated
by HPTLC (c). Microscopical evaluation of
HaCaT keratinocyte cultures treated for
5 h with 0.1% DMSO (a, c) or 0.1 mM
D609 (b, d). Transmission light (a, b) and
Hoechst nuclear staining (c, d) of either
area (  420). Note the shrinking of cells
and enlargement of intercellular spaces in
D609-treated cell cultures (b) and the
same numbers of nuclei in equal areas
(c, d) (d).
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only a minor increase in the rate of fl-SM synthesis (not
shown). In contrast, 5 mM fl-PC strongly increased the fl-SM
synthesis (Fig 7). The increase in fl-SM, however, was not
accompanied by the appearance of fluorescent diacylgly-
cerol (fl-DG) (not shown). The addition of 5 mM BODIPY-
diacylglyerol (fl-DG) did not affect the fl-SM synthesis
(Fig 7).
PC–SM transacylase The fl-PC-induced increase in fl-SM
synthesis was not caused by an improved availability of the
phosphocholine moiety. A fluorescent product that com-
igrated exactly with fl-C5-SM on HPTLC appeared when
isolated HaCaT keratinocyte membranes were allowed to
react solely with fl-C5-PC to which no fl-Cer was added
(Fig 8). Such an fl-SM-resembling band appeared also when
fl-PC was added to homogenates as well as to isolated
membranes of normal human keratinocytes (not shown).
Cultured intact HaCaT keratinocytes, however, did not con-
vert any of the added fl-PC to the putative fl-SM (Fig 1d ).
As the fluorophores resided in the acyl-chains of the lipid
analogs, the appearance of the fluorescent product must be
based on acyl-chain transfer. To elucidate the nature of fl-
PC’s reaction and degradation products, HaCaT keratino-
cyte membranes were incubated with 1,2-bis BODIPY FL
C11-phosphatidylcholine (bis-fl-PC), which is fluorescence
labeled in both its acyl-chains (Fig 9). The products
detectable on HPTLC were a double band with a mobility
between fl-C5-SM and fl-C5-PC, probably representing an
fl-C11-SM species (Fig 9a). In addition, a band migrating
slightly slower than bis-fl-PC was discernible at lower
intensifications (Fig 9b). This latter band might correspond
to the chromatographical behavior of a PC containing one
fluorescent fl-C11-chain and one unlabelled acyl-chain. The
equal band intensities of bis-fl-PC and PC containing only
one fl-C11-chain do not represent a comparable amount of
the individual lipid species, because emission of bis-fl-PC is
reduced by self-quenching of its adjacent fluorophores. No
fluorescent free-fatty-acids and no PC deacylated to
fluorescent lyso-phosphatidylcholine could be detected
(Fig 9).
The fluorescent reaction product of fl-C5-PC was tested
for being a substrate of SMase from B. cereus to further
identify it as a true SM analog. B. cereus SMase hydrolyzed
the putative fl-C5-SM to fl-Cer (Fig 10).
Discussion
Fluorescent short acyl-chain lipid analogs This study
relied on sphingo- and phospholipid analogs containing
fluorophore labeled short acyl-chains as they allow studies
on compartmentalization and metabolism in parallel.
Short-chain sphingolipids exist in mammalian tissues
(Karasawa et al, 1999), and their most relevant functional
difference is increased freedom of intermembrane move-
ment. Fl-Cer and fl-SM were applied in only double
amounts as compared with keratinocyte endogenous
contents (Pillai et al, 1999). The analogs were incorporated
and metabolized and did not provoke alterations regarding
morphology and rates of proliferation and apoptosis. As
reported for unlabeled short-chain analogs, only higher
concentrations of fl-Cer and fl-SM would presumably affect
keratinocyte proliferation (Geilen et al, 1996). This argues for
a compatible embedding of the fluorescent sphingolipids
and for the physiological relevance of results derived.
Fluorescent lipid analogs are increasingly used in studies
Figure 7
A fluorescence labeled phosphatidylcholine analog apparently
increases fl-SM synthesis. Fl-Cer, fl-Cer in combination with fl-PC,
and fl-Cer together with fl-DG were each added at a final concentration
of 5 mM to HaCaT keratinocyte membranes, and reactions proceeded
for 5 and 15 min. A typical HPTLC plate and, above, its densitometrical
evaluation are shown (m, Cer; ’, Cer þ PC;  , Cer þ DG).
Figure8
An fl-SM-resembling product appears when keratinocyte mem-
branes are allowed to react with fl-PC as the sole fluorescent
substrate. Fl-PC (C5-PC), fl-DG, fl-PC in combination with fl-SM, and
fl-DG plus fl-SM respectively were each added at a final concentration
of 5 mM to HaCaT keratinocyte membranes dispersed in a solution
containing 50 mM MOPS (pH 7.4), 5 mM BSA, but no added Mg2þ , and
reactions proceeded for 5 and 15 min. Note the band comigrating with
fl-SM (C5-SM) in reactions with fl-PC as the sole fluorescent substrate.
A typical HPTLC plate is shown.
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on metabolism and trafficking. They proved to be reason-
able substitutes for membrane lipids in terms of packing
similarity. Regarding metabolizing enzymes, they proved to
be comparable to radioactive probes (Loidl et al, 2002). To
confirm the reliability of our results, we studied inhibitory
competition by natural Cer and SM species. The turnover
rates of both fl-Cer and fl-SM decreased linearly according
to replacement with their natural counterparts (Fig 5). This
indicates that the enzymes involved do not discriminate
against the fluorophores used.
Cer–SM homeostasis The Cer–SM homeostasis disturbed
by incorporation of exogenous lipid analogs was rapidly
readjusted. This occurred already within the plasma
membrane because a considerable fraction of applied
lipids was metabolized before moving to intracellular
Figure 9
Keratinocyte membranes replace one of the two fluorescent acyl-chains of a double-labeled PC analog with an unlabeled acyl-chain and
transfer the other to SM. 1,2-bis BODIPY FL C11-PC was added at a final concentration of 5 mM to HaCaT keratinocyte membranes, and reactions
were allowed to proceed for times as indicated. On the right part of the HPTLC plate, BODIPY-labelled lipid standards as indicated are shown (a).
The same plate is shown at a lower intensification to discern the added bis-fl-PC (1,2-bis C11-PC, arrow) and a formed single-labeled PC analog
(lower part of the double band) (b). In addition, structure formulas of labeled SM and PC analogs are provided.
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compartments. In addition, enzymatic activities consuming
fluorescent sphingolipids were detected in preparations
enriched in plasma membranes. The turnover rates of fl-Cer
to fl-SM and vice versa were balanced. Evidence for the
reverse action of sphingomyelin synthase (SMS) was
reported (Van Helvoort et al, 1994), but the differential need
of Mg2þ in the SM hydrolyzing versus synthesizing activi-
ties points more to the presence of a Mg2þ -dependent
SMase and of a Mg2þ -independent SMS in keratinocytes. It
is unclear why neutral SMase activity was dominant not only
in membrane preparations but also in whole-cell extracts.
Fluorescent SM analogs and radiolabeled [3H]SM proved to
be comparable substrates for acid SMase (Loidl et al, 2002).
In a preparation containing the entire membrane population
of HaCaT keratinocytes, the activity of acid SMase was
reported to be 7-fold higher than that of neutral SMase
(Shimizu et al, 1999). Under the condition of an unstimulated
sphingomyelin cycle, neutral SMase could provide the
prevailing activity in the regulation of keratinocyte mem-
brane SM–Cer homeostasis, whereas induction of the SM
pathway could activate acid SMase.
There were no Cer phosphorylating or deacylating
activities detectable. These would have generated fl-Cer
species with altered mobility on HPTLC or fluorescent free-
fatty acids. Technically, however, ceramidase activity could
be determined with high sensitivity by using fluorescent
ceramide (He et al, 1999). In keratinocytes, the basal
activities of both Cer kinase and ceramidases appear
insignificant for the regulation of Cer concentration. Using
ceramidase inhibitors alone may not result in elevated Cer
levels.
D609 is regarded as a selective inhibitor of a PC-specific
phospholipase C and is also proposed to be a direct
inhibitor of SMS (Luberto and Hannun, 1998). The rate of
synthesis of fl-SM from fl-Cer was inhibited by D609 only for
short reaction times. When SMS activity was downregu-
lated by D609, SM hydrolysis in membrane preparations
was inhibited at a comparable degree, at the same time. As
SMS and SMase activities are obviously exerted by different
proteins, keratinocyte neutral SMase may be inhibited by
Cer. Thus, an initial D609-caused elevation of Cer concen-
tration would be balanced by decreased SMase activity to
result in restored relative levels of Cer and SM. Actually,
D609 left the overall phospholipid levels of keratinocytes
quantitatively unaltered. In leukemia cells and fibroblasts,
on the contrary, a positive feedback control of neutral
SMase by Cer was found (Jaffrezou et al, 1998). Such a self-
stimulation, once initiated, ensures Cer-induced apoptotic
destruction. A negative feedback control of neutral SMase
by Cer would more likely prevent apoptotic destruction. In
keratinocytes, Cer is additionally synthesized to become a
constituent of the epidermal lipid barrier. As a result, they
already contain an increased Cer to SM ratio as compared
to the leukemia cells (Pillai et al, 1999). Moreover, the dose
of exogenous Cer required to induce a maximal apoptotic
effect in the leukemia cells proved ineffective in keratino-
cytes (Geilen et al, 1996).
Morphological alterations in response to D609 treatment
were, however, obvious. D609 blocks DNA fragmentation
during apoptosis in endothelial cells (Miao et al, 1997). In
lymphocytes, it prevents cell spreading and attenuates
sodium influx (Wooten et al, 1999; Nofer et al, 2000). Cera-
mides can modify the permeability barrier of cell mem-
branes and can induce the efflux of ions and even of large
molecules (Montes et al, 2002). The 1.5 d half-life time of
D609 in tissue culture is longer than keratinocytes needed
to recover from shrinking. An initial D609-caused elevation
of Cer concentration could possibly have induced efflux and
shrinking. Recovery might be based on resynthesis.
Calcium chelators are used in studies on the effects
of the release of Ca2þ dependent intercellular contacts.
Extracellular calcium depletion, however, may affect intra-
cellular Ca2þ homeostasis. This unintentionally influences
a variety of other cellular Ca2þ functions. D609 induced a
temporary loss of intercellular contacts. In studies on
contact release, D609 might displace technical disadvanta-
geous changes of Ca2þ concentrations.
In conclusion, keratinocytes are well equipped for
preserving their Cer to SM ratio, and inhibition of selected
metabolizing activities seems ineffective for a sustained
therapeutical elevation of Cer levels.
PC–SM transacylase As de novo synthesis cannot provide
glycerophospholipids with sufficiently defined fatty acids,
mammalian cells extensively remodel their fatty-acid com-
position by deacylation/reacylation (Lands and Crawford,
1976). Multiple types of phospholipases, acyltransferases,
and transacylases are involved. Direct transfer of fatty acids
between glycerophospholipids, without the generation of
free fatty-acids, is catalyzed by CoA-dependent and
-independent transacylases. The latter exhibit a specificity
toward arachidonic acid and related polyunsaturated fatty
acids (MacDonald and Sprecher, 1991; Yamashita et al,
1997). The importance of precise fitting acyl-chain length
and saturation is shown clearly by mutant yeast cells that
Figure 10
Transacylated fl-SM is a substrate of SMase from B. cereus. Fl-C5-
PC at a final concentration of 5 mM was added to homogenized normal
human keratinocytes, and the reaction proceeded for 15 min at 371C.
Then, enzymatic reactions were terminated by heating. The solution
was aliquoted, and 5 mM MgCl2 and either 0.13 U SMase from B.
cereus (þ ) or glycerol at a final concentration of 1% () were added.
After a reaction time of 1 h at 371C, lipids were extracted and separated
by HPTLC.
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synthesize C24:0 instead of their normal C26:0 fatty-acid-
containing sphingolipids. To balance this alteration, the
mutant cells accumulate di- instead of monounsaturated
acyl-chains containing phosphatidylserin molecules in their
plasma membranes (Schneiter et al, 1999). Compared with
the variety of fatty acids present in glycerophospholipids,
the fatty-acid composition in SM is uniform. The bulk of
mammalian SM molecules may be grouped into two typical
classes which contain either C16:0 and C18:0 or C22:0,
C24:0, and C24:1 amide-linked acyl-chains (Holthuis et al,
2001). Such a fatty-acid composition contrasts with that
of glycerophospholipids and contributes to the structural
differences of the two phospholipid classes in membranes.
A small fraction of SM contains other fatty acids however.
Sertoli cells have C18:3 acyl-chains in SM (Ziulkoski et al,
2001), and testis and spermatozoa harbor SM species with
very long polyunsaturated fatty acids (Robinson et al, 1992).
Ras-transformed fibroblasts contain 85% less SM with
C20:4 chains (Laurenz et al, 1996). Fibroblasts loaded with
cholesterol adjust the fatty-acid content of SM toward
increasingly unsaturated acyl-chains, probably to counter-
act the membrane-rigidifying effect of cholesterol (Blom
et al, 2001). The trigger for fatty-acid transfer under the
experimental conditions used in this study may reside in the
asymmetry of carbon chain lengths in the fluorescent
analogs, which is more unusual for PC than for SM.
The transfer of acyl-chains between PC and SM as found
in keratinocytes for fluorescent analogs would provide an
elegant molecular mechanism of fatty-acid remodeling.
Within the plasma membrane, the putative PC–SM trans-
acylase would allow for a rapid adjustment of local lipid
compositions in response to acutely changed conditions.
An example for such a condition might be a surplus of
cholesterol.
An epidermis-specific function of the PC–SM trans-
acylase could reside in the formation of the permeability
barrier. A significant part of stratum corneum lipids is
formed by ceramides. These ceramides differ in their type of
sphingoid base as well as in chain length and saturation of
esterified fatty acids. Some Cer species contain linoleic acid
ester linked to o-hydroxy fatty acids (Ponec et al, 2003).
Substitution of oleate for linoleate in these special Cer
molecules results in a profound barrier abnormality (Ponec,
1994). Glucosylceramides are the major precursors of
stratum corneum ceramides; however, a fraction of cer-
amides is derived from SM (Uchida et al, 2000). These SM-
derived Cer species are required for normal permeability
barrier function (Schmuth et al, 2000). The availability of
linoleic acid as a free fatty acid seems to be of secondary
importance for the rate of its incorporation into stratum
corneum ceramides (Ponec et al, 2003). Possibly, the PC–
SM transacylase is involved in tuning up the fatty-acid
profile of SM for later use in stratum corneum ceramides.
The term transacylase fits the yet undescribed activity,
as there were no free fatty-acids and no deacylated PC
and SM molecules detectable. Known molecular relations
between PC and SM are the competitive inhibition of
lecithin–cholesterol acyltransferase (LCAT) (Bolin and Jo-
nas, 1996) as well as the inhibition of secretory type II
phospholipase A2 by SM (Koumanov et al, 2002). In these
reactions however, SM does not serve as a substrate. An
SM-deacylating activity generating free fatty acids is
connected to atopic dermatitis (Hara et al, 2000; Higuchi
et al, 2000).
Cer is the substrate in fatty-acid remodeling by cerami-
dases and ceramide synthases. These enzymes are, how-
ever, dependent on free fatty-acids (Okabe and Kishimoto,
1977; El Bawab et al, 2001). The recently described enzyme
1-O-acylceramide synthase has sequence similarities with
LCAT. It contains phospholipase A2 and transacylase
activities. However, 1-O-acylceramide synthase transfers
the sn-2-acyl group of either phosphatidylethanolamine or
PC to the 1-hydroxyl group of ceramide (Taniyama et al,
1999; Hiraoka et al, 2002). Another enzyme was purified that
catalyzes a CoA-independent acetate transfer from platelet
activating factor (PAF) to sphingosine. The acetate is then
amide-linked to form N-acetylsphingosine (C2-Cer). Cer,
SM, and deacylated SM are no substrates of this enzyme
(Karasawa et al, 1999). This activity, however, documents
the feasibility of transacylation between O- and N-linked
chains.
Counteracting environmentally induced alterations in
membrane fluidity and stability by in situ fatty-acid replace-
ment between PC and SM seems to be of apparent
significance, and efforts to isolate and characterize the
putative transacylase appear reasonable.
Materials and Methods
Cell culture, homogenates, membranes HaCaT keratinocytes
(kindly provided by N.E. Fusenig, DKFZ, Heidelberg, Germany)
were cultured in a humidified atmosphere containing 5% CO2 at
371C in DMEM without phenol red (Life Technologies, Eggenstein,
Germany), which was supplemented with 5% FCS (GibcoBRL,
Karlsruhe, Germany) delipidized using 1% dextran-coated char-
coal (Sigma, Deisenhofen, Germany), with 4 U per mL penicillin/
streptomycin (Sigma) and with 1 mM L-glutamine (Seromed, Berlin,
Germany). The medium was changed twice a week. Normal human
skin specimens were obtained as residual material after reduction
mammoplasty with approval of the local ethic commission. Skin
stripes were incubated for 18 h at 41C in phosphate-buffered saline
(PBS) containing 3 RMB units dispase I (Roche, Mannheim,
Germany). After stripping off the dermis, epidermal sheets were
incubated for 15 min at 371C in PBS containing 0.25% trypsin
(Biochrom, Berlin, Germany) and 0.01% DNase (Roche, Man-
nheim, Germany). Single-cell suspensions of epidermal cells were
then prepared by passaging through 40 mm cell strainers (BD,
Heidelberg, Germany). To obtain a pure keratinocyte suspension,
Langerhans cells were removed by labeling them with mouse
anti-human CD1a antibodies coupled to superparamagnetic
microbeads (Miltenyi Biotech, Bergisch Gladbach, Germany) and
by magnetic activated cell sorting on large-cell separation columns
(Miltenyi Biotech). The fraction of normal human keratinocytes was
then cultured as HaCaT keratinocytes. For preparation of whole-
cell homogenates, keratinocytes were harvested using a rubber
policeman and were then suspended in 50 mM MOPS (pH 7.4),
1 mM EDTA, 1  complete mini EDTA-free protease inhibitor
cocktail (Roche) at a density of 107 cells per mL and sonified twice
for 5 s on ice at 70 W using a Branson B-12 sonifier (Branburry,
Connecticut). Membranes of normal human and of HaCaT
keratinocytes were prepared by nitrogen cavitation and differential
centrifugation as this has proven to be the method of choice to
receive pure plasma membranes (Watarai et al, 2000). Cells were
harvested using trypsin and then suspended in 20 mM Hepes (pH
8.0), 1 mM EDTA, 0.1 mM EGTA, 150 mM NaCl, 2 mM DTT, 1 
protease inhibitor cocktail at a density of 107 cells per mL,
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transferred into a small-size nitrogen bomb, and incubated at
30–50 bar, 21C for 30 min. The suspension was released and
centrifuged at 21C in a Heraeus megafuge (Kendro, Berlin,
Germany). When a velocity of 500 g was reached, the centrifuga-
tion was stopped without using brakes. The supernatants were
spun at 500 g for 30 min at 21C. Thereafter, supernatants were
discarded, and pellets were homogeneously resuspended in
20 mM Hepes (pH 8.0), 1 mM EDTA, 1  protease inhibitor cocktail,
2 mM DTT, 5.7% sucrose and were dribbled dropwise into liquid
nitrogen. The frozen balls were stored at 801C. For assays, only
the necessary number of balls was thawed. The typical protein
concentration was in the range of 4 mg per mL as determined by
using a Micro BCA protein assay kit (Pierce, Rockford, Illinois).
Assays for subcellular membranes For western blotting, 50 mg
total protein of the membrane preparations were separated by
SDS–PAGE (4% stacking /12% resolving gel) and semi-dry blotted
to Protran nitrocellulose membranes (Schleicher & Schu¨ll, Dassel,
Germany). Golgi 58K-protein antibody (Sigma) was used at a
dilution of 1:5000 and peroxidase-conjugated rabbit-anti-mouse
immunoglobulin (Dako, Hamburg, Germany) at 1:500. Visualization
was performed using Super Signal West Pico Chemiluminescent
Substrate (Pierce). To determine alkaline phosphatase activity,
probes were incubated in 125 mM sodium borate NaOH, pH 9.8,
8 mM p-nitrophenylphosphate (Sigma), 2 mM MgCl2 for 1 h at
371C, and hydrolysis was terminated by adding 3 volumes of 0.25
M NaOH and measured at 410 nm in a Cary 1E photometer (Varian,
Darmstadt, Germany).
Labeling of keratinocyte cultures with ﬂuorescent lipids and
addition of D609 The cell culture media were renewed and MOPS
(pH 7.4) was added at a final concentration of 50 mM. Then, the
cell cultures were cooled to 41C. It was not necessary to produce
liposomes. All of the lipid probes used were fluorescent labeled at
the o-carbon of the fatty acid esterified to the sphingoid base or to
the glycerol backbone, respectively. BODIPY FL C5-ceramide,
BODIPY FL C5-sphingomyelin, BODIPY FL C5-HPC, and 1,2-bis-
BODIPY FL C11-PC (all from Molecular Probes Europe, Leiden, The
Netherlands) were dissolved in DMSO at a concentration of 5 mM
and were simply added to the cell culture media resulting in a
1000-fold dilution. After incubation for 10 min at 41C, media were
removed, fresh media without labeled lipids were added, and the
cell cultures were transferred to a 371C incubator. C2-Cer (N-
acetyl-D-sphingosine) (Sigma) was dissolved in DMSO.
D609 (Calbiochem, Darmstadt, Germany) was dissolved
in DMSO. Its addition to cell culture media containing MOPS
(pH 7.4) or to assays using either homogenates or membranes as
the source of enzyme resulted in final DMSO concentrations of
0.1%.
Microscopy Microscopy was performed using a Leica DMRBE
fluorescence microscope (Bensheim, Germany) equipped with a
Hg lamp, a Leica  40 water-immersion objective, filter sets from
Omega Optical (Seefeld, Germany), and a Hamamatsu digital
camera C4742-95 (Herrsching, Germany). Images were taken
using Openlab software (Improvision, Heidelberg, Germany). To
stain the nuclei, Hoechst 33342 (Molecular Probes Europe) was
used at a concentration of 2.5 mg per mL. To determine cellular
viability and apoptosis, the cell culture medium was removed, and
a solution of 50 mM MOPS (pH 7.4), 140 mM NaCl, 2.5 mM CaCl2
(2 mL per 6 cm dish) was added. Then 7-amino-actinomycin and
annexin V-PE (each at 45 mL per 6 cm dish) (both from PharMingen
Europe, Hamburg, Germany) were added. After 20 min at 371C, the
staining solutions were removed, and cell cultures were washed
with the MOPS solution and microscoped therein.
FACS For flow cytometry, cells were harvested and washed in
PBS. 105 cells of each sample were resolved in 2 mL of a solution
of 10 mM HEPES (pH 7.4), 140 mM NaCl, and 2.5 mM CaCl2
(or without Ca for control). To 500 mL thereof, 1 mL fluorescein-
isothiocyanate labeled annexin V (Alexis, Gru¨nberg, Germany) and
20 mL propidium iodide (0.001%) (Sigma) were added. After 15 min,
proportions of labeled cells were measured in a FacsCalibur
(Becton Dickinson, Heidelberg, Germany).
Fluorescent lipid metabolism For metabolic assays of fluores-
cent lipids in labeled intact keratinocytes, the cell culture media
were removed after individual reaction times, plates were washed
with cold PBS, and then a small volume of cold PBS (500 mL per
6 cm dish) was added. The cells were scraped from the plate
with a rubber policeman, collected, and centrifuged for 1 min
at 500 g. The supernatants were removed, and 100 mL of
chloroform:methanol¼ 2:1 were added. After stirring for 1 h at
room temperature, the organic phase was separated and used for
HPTLC. For assays of enzymatic activities in both homogenates
and membrane preparations, fluorescent lipid at a final concentra-
tion of 5 mM was injected into a stirring solution of 50 mM MOPS
(pH 7.4), 5 mM fatty-acid free bovine albumin (Sigma). Ions or
modulators were added as individually indicated. This solution was
placed on ice, and homogenates or membrane preparations were
added to result in final keratinocyte protein concentrations of
0.2 mg/mL. Reactions were initiated by transfer to 371C and
terminated by transfer to ice and immediate addition of the double
volume of chloroform:methanol¼ 2:1 (v:v). After stirring for 1 h at
room temperature, the organic phase was separated and used for
HPTLC. Thin-layer chromatography was performed on silica gel 60
HPTLC glass plates (Merck, Darmstadt, Germany) using a mixture
of chloroform:methanol:H2O¼ 55:20:3 (v:v:v) as mobile phase.
Fluorescence intensities were determined by UV light exposure in a
gel doc 2000 station (Biorad, Mu¨nchen, Germany). Densitometry
was performed using IPLab Gel (Signal Analytics, Vienna, Virginia).
Images were processed using Photoshop 5.0 (Adobe Systems San
Jose, California). Standards for band identification and quantitation
were commercially available BODIPY FL lipids (Molecular Probes)
as well as BODIPY FL lipids prepared thereof. For C5-BODIPY FL-
diacylglyerol, BODIPY FL C5-HPC was hydrolyzed using phos-
pholipase C type IV from bacillus (B. cereus) (Sigma). The resulting
product was separated by HPTLC, excised from the plate, and
redissolved in DMSO. For C11-BODIPY FL lyso-phosphatidylcho-
line and for C11-BODIPY FL free fatty acid, 1,2-bis-BODIPY FL C11-
PC was hydrolyzed using phospholipase A2 from bee venom
(Sigma). For C11-BODIPY FL monoacylglycerol, 1,2-bis-BODIPY
FL C11-PC was hydrolyzed by both phospholipase A2 and
phospholipase C. Natural sphingomyelin from bovine brain (Sigma)
and natural C18-Cer N-stearoyl-D-sphingosine (Sigma) were dis-
solved in warm ethanol. Neutral SMases from B. cereus and
staphylococcus (S. aureus) and acidic SMase from human
placenta were from Sigma. Endogenous lipids separated on silica
gel 60 F254 glass plates (Merck) were developed for 10 s in 2
0,70-
dichlorfluorescein (Merck) 1/10 in isopropanol, and bands were
visualized by exposure to UV light.
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